Animal Placental Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Animal Placental Protein Market is projected to expand from USD 544.62 Million in 2025 to USD 740.75 Million by 2031, registering a CAGR of 5.26%. This bioactive ingredient, derived from the postpartum tissues of mammals like swine, sheep, and horses, is prized for its rich content of enzymes, amino acids, and growth factors. The market's growth is largely fueled by the booming cosmeceutical industry, which demands potent anti-aging ingredients, and the rising application of regenerative therapies for tissue repair. Furthermore, increasing consumer interest in nutrient-rich, organ-based dietary supplements is strengthening commercial demand for these specialized protein fractions.

However, the sector encounters significant obstacles arising from strict regulations designed to prevent disease transmission and ensure the biological safety of animal by-products. Data from the China Animal Agriculture Association indicates that in 2024, the industry strategically reduced the breeding sow herd by roughly 1 million heads to manage market oversupply, a move that directly limits the availability of raw materials for porcine placental protein. This variability in livestock numbers poses a considerable challenge for manufacturers who depend on porcine sources to maintain stable production volumes.

Market Drivers

A primary catalyst for the global animal placental protein market is the escalating demand for skin rejuvenation and anti-aging cosmetic products. With consumers increasingly favoring non-invasive aesthetic improvements, there is a corresponding surge in the use of bioactive ingredients that promote collagen synthesis and accelerate post-procedure recovery. This trend is supported by June 2024 data from the International Society of Aesthetic Plastic Surgery, which reported 19.1 million non-surgical procedures globally in the previous year, establishing a strong market for placenta-infused aftercare solutions. Manufacturers are responding by incorporating protein fractions into cosmeceuticals that replicate the regenerative benefits of clinical treatments, driving substantial procurement of raw extracts.

Simultaneously, the market is bolstered by growing applications in wound care therapeutics and regenerative medicine, where animal-derived scaffolds are crucial for tissue engineering. Recent clinical progress has confirmed the effectiveness of these biological matrices for complex skin injuries, enhancing their medical acceptance. For example, a real-world study published in Cureus in December 2024 showed that porcine placental extracellular matrix facilitated complete closure in 53% of hard-to-heal wounds, highlighting its therapeutic value. To sustain these medical-grade uses, the supply chain remains robust; Deer Industry New Zealand reported that exports of deer co-products, a vital source for bioactive extraction, reached 4,944 tonnes in the year ending September 2024, ensuring the high-quality raw material availability needed for the therapeutic sector.

Market Challenges

The main obstacle to market growth is the inconsistency of raw material supply chains caused by fluctuations in global livestock inventories. Because animal placental protein production depends entirely on collecting postpartum tissue, the industry is highly sensitive to any reductions in equine, ovine, or swine herd sizes. When breeding populations shrink due to economic factors, disease outbreaks, or regulatory herd management, the quantity of extractable biological material falls. This reliance creates major production bottlenecks, making it difficult for manufacturers to maintain the inventory levels necessary to satisfy increasing commercial demand.

According to the American Sheep Industry Association, the total inventory of sheep and lambs in the United States fell by 2 percent in 2024, indicating a persistent contraction in ovine sources. This decline in the biological foundation directly limits the supply capacity for ingredients derived from sheep. Consequently, manufacturers must contend with intensified competition for scarce resources and rising procurement costs, which hinders their ability to expand operations and slows the overall growth of the placental protein sector.

Market Trends

The market is being reshaped by a marked increase in the use of porcine-derived placental protein in Korean cosmetic formulations, driven by the ingredient's strong histocompatibility with human skin and the global reach of K-Beauty brands. As manufacturers update ampoules and sheet masks to leverage this biological affinity, exports of these finished products have surged, requiring greater volumes of porcine raw materials to fulfill international demand. This trend is confirmed by trade data from the Korea Customs Service in January 2025, which notes that skincare exports to the United States more than tripled to $815.1 million in 2024, highlighting the massive commercial channel through which these placenta-enriched products are entering Western markets.

Concurrently, there is a rapid emergence of Halal-certified ovine placenta extracts aimed at strictly regulated consumer markets in the Middle East and Southeast Asia. To ensure religious compliance, producers are increasingly replacing porcine ingredients with sheep-derived alternatives, a strategy supported by record biological availability from major exporters like Australia. This supply capacity is essential for meeting Halal requirements; according to Meat & Livestock Australia’s September 2024 'Sheep Industry Projections' report, the national flock peaked at 79.1 million head in June 2024, the highest level since 2007, providing a traceable and stable raw material base for these specialized formulations.

Key Players Profiled in the Animal Placental Protein Market

• Merck KGaA
• Biotain Pharma Co., Ltd.
• New Zealand Health Food Company Limited
• XABC Biotech Co., Ltd.
• Chaitanya Biologicals Pvt. Ltd.
• Serolab SA
• Auckland BioSciences Limited
• ANZCO Foods Limited
• Biocontinental Co., Ltd.

Report Scope

In this report, the Global Animal Placental Protein Market has been segmented into the following categories:

Animal Placental Protein Market, by Product Type:

• Extracts
• Powders
• Capsules/Tablets
• Injections

Animal Placental Protein Market, by Application:

• Pharmaceuticals
• Cosmetics and Personal Care Products
• Nutraceuticals and Dietary Supplements
• Research
• Biotechnology

Animal Placental Protein Market, by Animal Source:

• Bovine
• Porcine
• Ovine
• Equine
• Others

Animal Placental Protein Market, by Distribution Channel:

• Direct Sales
• Retail Sales
• Online Retail

Animal Placental Protein Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Placental Protein Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.